Home Crown Bioscience To Commercialize University Of York's Prostate Cancer Models For Drug Development
 

Keywords :   


Crown Bioscience To Commercialize University Of York's Prostate Cancer Models For Drug Development

2016-02-17 02:07:05| drugdiscoveryonline News Articles

Crown Bioscience Inc., a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has reached an agreement with UK’s University of York to exclusively license and commercialize the university’s unique collection of patient-derived xenograft (PDX) models for prostate cancer.

Tags: development university models drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
19.05Eastern North Pacific Tropical Weather Outlook
19.05Atlantic Tropical Weather Outlook
19.05'I had no choice but to get a 35-year mortgage'
19.05Fujitsu sacked boss at height of Horizon scandal
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05Businessman Tony O'Reilly dies after short illness
18.05Eastern North Pacific Tropical Weather Outlook
More »